Offres d'emploi
Trouvez des postes près de chez vous, sur site, hybrides ou à distance.- Emplois similaires à : Facilities Manager - Cannock
Facilities Manager - Oxford
ImmunocoreBartonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreCumnorFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreMarsh BaldonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreEynshamFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreStanton HarcourtFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBladonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreCulhamFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreClifton HampdenFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBishopstoneFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocorePrinces RisboroughFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreEast ClaydonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreTingewickFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreColeshillFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreGawcottFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreLittle KimbleFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreHinton in the HedgesFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreLeckhampsteadFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreAylesburyFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreWaltonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreSonning CommonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreLittle RollrightFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreSpeenFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreLambournFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBuckinghamFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreEastburyFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor